IN2015DN03796A - - Google Patents
Info
- Publication number
- IN2015DN03796A IN2015DN03796A IN3796DEN2015A IN2015DN03796A IN 2015DN03796 A IN2015DN03796 A IN 2015DN03796A IN 3796DEN2015 A IN3796DEN2015 A IN 3796DEN2015A IN 2015DN03796 A IN2015DN03796 A IN 2015DN03796A
- Authority
- IN
- India
- Prior art keywords
- gene signatures
- autoimmune disorders
- metabolic
- inflammation
- disorders
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
- C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/16—Primer sets for multiplex assays
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Analytical Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Immunology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP12306286 | 2012-10-17 | ||
| PCT/EP2013/071793 WO2014060555A1 (en) | 2012-10-17 | 2013-10-17 | Gene signatures of inflammatory disorders that relate to the liver |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2015DN03796A true IN2015DN03796A (pt) | 2015-10-02 |
Family
ID=47148686
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN3796DEN2015 IN2015DN03796A (pt) | 2012-10-17 | 2013-10-17 |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US10036074B2 (pt) |
| EP (1) | EP2909334B1 (pt) |
| JP (2) | JP6752016B2 (pt) |
| CN (1) | CN104769132B (pt) |
| AU (2) | AU2013333882B2 (pt) |
| BR (1) | BR112015008621A2 (pt) |
| CA (1) | CA2886748A1 (pt) |
| DK (1) | DK2909334T3 (pt) |
| ES (1) | ES2821383T3 (pt) |
| IL (1) | IL238025B (pt) |
| IN (1) | IN2015DN03796A (pt) |
| MX (1) | MX2015004844A (pt) |
| NZ (1) | NZ707035A (pt) |
| WO (1) | WO2014060555A1 (pt) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10039777B2 (en) | 2012-03-20 | 2018-08-07 | Neuro-Lm Sas | Methods and pharmaceutical compositions of the treatment of autistic syndrome disorders |
| EP4249053A3 (en) | 2016-03-04 | 2024-06-19 | The Regents of The University of California | Microbial consortium and uses thereof |
| JP2019517783A (ja) * | 2016-04-20 | 2019-06-27 | ヒューマン ロンジヴィティ，インコーポレイテッド | 肝疾患を検出するためのマイクロバイオーム（ｍｉｃｒｏｂｉｏｍｅ）プロファイルの使用 |
| CA3024272A1 (en) * | 2016-05-11 | 2017-11-16 | University Of Southern California | Fasting mimicking diet (fmd) as an immunoregulatory treatment for gastrointestinal autoimmune/inflammatory diseases. |
| US11284640B2 (en) | 2017-02-14 | 2022-03-29 | University Of Southern California | Fasting mimicking diet |
| EP3606325A4 (en) | 2017-04-03 | 2021-01-20 | Gusto Global, LLC | RATIONAL DESIGN OF BIOTHERAPEUTICS BASED ON MICROBES |
| CN107271674B (zh) * | 2017-06-13 | 2019-05-07 | 首都医科大学附属北京地坛医院 | 一种用于脂肪性肝炎检测的靶标志物gp73及检测应用方法 |
| EP3773645A4 (en) | 2018-04-10 | 2021-11-24 | Siolta Therapeutics, Inc. | MICROBIAL CONSORTIA |
| CN108504739A (zh) * | 2018-05-15 | 2018-09-07 | 浙江大学 | 一种用于肝癌早期诊断的生物标志物及其应用 |
| EP3899015A1 (en) * | 2018-12-19 | 2021-10-27 | Astrazeneca AB | Biomarker of pnpla3 expression |
| JP2022523564A (ja) | 2019-03-04 | 2022-04-25 | アイオーカレンツ， インコーポレイテッド | 機械学習を使用するデータ圧縮および通信 |
| CA3153884A1 (en) | 2019-10-07 | 2021-04-15 | Nikole KIMES | Therapeutic pharmaceutical compositions |
| CN111884792B (zh) * | 2020-06-30 | 2021-07-09 | 深圳市永达电子信息股份有限公司 | 基于忆阻器混沌序列的本征态网络电路信号制备系统和方法 |
| US11688507B2 (en) | 2020-12-29 | 2023-06-27 | Kpn Innovations, Llc. | Systems and methods for generating a metabolic dysfunction nourishment program |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6582908B2 (en) * | 1990-12-06 | 2003-06-24 | Affymetrix, Inc. | Oligonucleotides |
| US6610836B1 (en) * | 1999-01-29 | 2003-08-26 | Genome Therapeutics Corporation | Nucleic acid amino acid sequences relating to Klebsiella pneumoniae for diagnostics and therapeutics |
| JP4852211B2 (ja) * | 2000-03-21 | 2012-01-11 | メルク アンド カンパニー インコーポレイテッド | 原核生物における必須遺伝子の同定 |
| EP1227152A1 (en) * | 2001-01-30 | 2002-07-31 | Société des Produits Nestlé S.A. | Bacterial strain and genome of bifidobacterium |
| WO2003053220A2 (en) * | 2001-12-17 | 2003-07-03 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of inflammatory bowel disease |
| US8119365B2 (en) * | 2002-01-23 | 2012-02-21 | Wisconsin Alumni Research Foundation | Insertion sequence-free bacteria |
| WO2004092365A1 (ja) * | 2003-04-13 | 2004-10-28 | Kyushu Tlo Company Limited | 肝障害関連遺伝子群の抽出選択法およびそれを用いた肝障害もしくは肝機能評価・診断方法 |
| US7860656B2 (en) * | 2005-02-03 | 2010-12-28 | Assistance Publique-Hopitaux De Paris (Ap-Hp) | Diagnosis method of hepatic steatosis using biochemical markers |
| SI2351772T1 (sl) * | 2005-02-18 | 2016-11-30 | Glaxosmithkline Biologicals Sa | Proteini in nukleinske kisline iz Escherichia coli povezane z meningitisom/sepso |
| FR2893136A1 (fr) * | 2005-11-10 | 2007-05-11 | Sanofi Aventis Sa | Procedes de diagnostic de maladies hepatiques et de criblage de molecules pour le traitement de ces maladies |
| US20110165568A1 (en) * | 2009-12-31 | 2011-07-07 | Life Technologies Corporation | Sequences of e.coli 055:h7 genome |
| AU2011223049B2 (en) * | 2010-03-01 | 2015-06-18 | Institut National De La Recherche Agronomique | Method of diagnostic of inflammatory bowel diseases |
| JP5757032B2 (ja) * | 2010-04-05 | 2015-07-29 | 学校法人東京医科大学 | ｍｉＲＮＡを利用した慢性肝疾患の線維化の検査方法 |
| JP2012125215A (ja) * | 2010-12-17 | 2012-07-05 | Osaka City Univ | 肝線維症の存在及び／又は肝線維症の重症度の判定方法、判定マーカー、判定用キット、肝線維症の治療の効果予測方法、効果予測マーカー、並びに効果予測用キット |
| WO2012105590A1 (ja) * | 2011-02-01 | 2012-08-09 | アステラス製薬株式会社 | 非アルコール性脂肪肝炎の鑑別マーカー及び当該マーカーを指標とした非アルコール性脂肪肝炎の診断方法 |
| WO2012159023A2 (en) * | 2011-05-19 | 2012-11-22 | Virginia Commonwealth University | Gut microflora as biomarkers for the prognosis of cirrhosis and brain dysfunction |
| EP2763540A4 (en) | 2011-09-09 | 2015-04-22 | Univ Yale | COMPOSITIONS AND METHODS FOR EVALUATION AND TREATMENT OF DISEASES AND INFLAMMATORY DISORDERS |
| US20140377278A1 (en) * | 2012-01-10 | 2014-12-25 | Yale University | Compositions and Methods for Assessing and Treating Inflammatory Diseases and Disorders |
| ES2683826T3 (es) | 2012-10-17 | 2018-09-28 | Institute National De La Recherche Agronomique | Determinación de la diversidad bacteriana intestinal reducida |
| US20150284779A1 (en) | 2012-10-17 | 2015-10-08 | Institut National De La Recherche Agronomique | Determination of a tendency to gain weight |
| MX2015004809A (es) | 2012-10-17 | 2015-11-16 | Agronomique Inst Nat Rech | Pronostico del impacto de la dieta sobre las co-morbilidades relacionadas con la obesidad. |
| US9459650B2 (en) | 2014-03-17 | 2016-10-04 | Qualcomm Incorporated | Clock pulse generator for multi-phase signaling |
-
2013
- 2013-10-17 MX MX2015004844A patent/MX2015004844A/es active IP Right Grant
- 2013-10-17 CA CA2886748A patent/CA2886748A1/en not_active Abandoned
- 2013-10-17 EP EP13779214.9A patent/EP2909334B1/en active Active
- 2013-10-17 CN CN201380054047.XA patent/CN104769132B/zh not_active Expired - Fee Related
- 2013-10-17 DK DK13779214.9T patent/DK2909334T3/da active
- 2013-10-17 JP JP2015537267A patent/JP6752016B2/ja not_active Expired - Fee Related
- 2013-10-17 ES ES13779214T patent/ES2821383T3/es active Active
- 2013-10-17 NZ NZ707035A patent/NZ707035A/en not_active IP Right Cessation
- 2013-10-17 US US14/435,750 patent/US10036074B2/en active Active
- 2013-10-17 BR BR112015008621-7A patent/BR112015008621A2/pt not_active Application Discontinuation
- 2013-10-17 IN IN3796DEN2015 patent/IN2015DN03796A/en unknown
- 2013-10-17 WO PCT/EP2013/071793 patent/WO2014060555A1/en active Application Filing
- 2013-10-17 AU AU2013333882A patent/AU2013333882B2/en not_active Ceased
-
2015
- 2015-03-30 IL IL238025A patent/IL238025B/en active IP Right Grant
-
2018
- 2018-05-07 US US15/972,620 patent/US10626471B2/en active Active
-
2019
- 2019-03-05 JP JP2019039947A patent/JP2019092522A/ja active Pending
- 2019-08-02 AU AU2019210666A patent/AU2019210666A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20180251819A1 (en) | 2018-09-06 |
| JP2015535177A (ja) | 2015-12-10 |
| ES2821383T3 (es) | 2021-04-26 |
| BR112015008621A2 (pt) | 2018-08-28 |
| IL238025B (en) | 2020-05-31 |
| AU2013333882B2 (en) | 2019-05-16 |
| MX2015004844A (es) | 2015-11-16 |
| IL238025A0 (en) | 2015-05-31 |
| DK2909334T3 (da) | 2020-09-28 |
| US10036074B2 (en) | 2018-07-31 |
| CN104769132B (zh) | 2018-05-08 |
| JP2019092522A (ja) | 2019-06-20 |
| EP2909334A1 (en) | 2015-08-26 |
| NZ707035A (en) | 2018-11-30 |
| JP6752016B2 (ja) | 2020-09-09 |
| AU2019210666A1 (en) | 2019-08-22 |
| WO2014060555A1 (en) | 2014-04-24 |
| US20160068890A1 (en) | 2016-03-10 |
| CN104769132A (zh) | 2015-07-08 |
| CA2886748A1 (en) | 2014-04-24 |
| EP2909334B1 (en) | 2020-06-24 |
| US10626471B2 (en) | 2020-04-21 |
| AU2013333882A1 (en) | 2015-05-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2015DN03796A (pt) | ||
| CA2941917C (en) | Methods for the diagnosis and treatment of inflammatory bowel disease | |
| MX2016002879A (es) | Sistemas, dispositivos y metodos para la terapia anti-tl1a. | |
| MX2016014624A (es) | Metodos para el tratamiento de enfermedad inflamatoria del intestino. | |
| WO2012047631A3 (en) | Compositions and methods useful for the treatment and diagnosis of inflammatory bowel disease | |
| NZ602704A (en) | Method of diagnostic of inflammatory bowel diseases | |
| MX2015015784A (es) | Metodos para diagnosticar y tratar enfermedad inflamatoria de intestino. | |
| MX2017015210A (es) | Composiciones y metodos para el cribado de tumores solidos. | |
| PH12016502167A1 (en) | Hdl theraphy markers | |
| IN2014MN01642A (pt) | ||
| MX2022012384A (es) | Composiciones y metodos para cribar mutaciones en el cancer de tiroides. | |
| MX2022010809A (es) | Antagonistas de integrina-beta7 para usarse en el tratamiento y diagnostico de trastornos inflamatorios gastrointestinales. | |
| NZ738100A (en) | Igfbp3 and uses thereof | |
| HK1159659A1 (en) | Treatment of autoimmune disease by modulating annexin-1 (lipocortin 1) -i( i) | |
| BR112017014107A2 (pt) | composição nutricional útil no tratamento de pacientes com ibd | |
| MX344543B (es) | Metodos y composiciones para prediccion de riesgo, diagnosis, prognosis y tratamiento de desordenes pulmonares. | |
| ZA201408059B (en) | Compositions and methods for the treatment of inflammatory bowel disease | |
| EP3052661A4 (en) | Methods for assessing status of post-transplant liver and determining and administering specific treatment regimens | |
| MX2022008842A (es) | Proteinas para el tratamiento de trastornos de la funcion de la barrera epitelial. | |
| MA40592A (fr) | Compositions et méthodes pour le traitement d'une maladie inflammatoire de l'intestin à l'aide d'une polythérapie à base d'inhibiteurs à petites molécules de récepteur 9 de chimiokine c-c (ccr9) et d'anticorps bloquants anti-intégrine alpha4beta7 | |
| HRP20190211T1 (hr) | Inhibitor proteina za prijenos kolesterilestera (cetp) i farmaceutski pripravci koji sadrže spomenuti inhibitor za primjenu u liječenju ili prevenciji kardiovaskularnih bolesti | |
| MX2017006959A (es) | Metodos para establecer un regimen de dosificacion de vedolizumab para tratar pacientes con enfermedad del intestino irritable. | |
| IN2014DN06662A (pt) | ||
| WO2013106766A3 (en) | THERAPEUTIC INDICATIONS OF miR-1291 | |
| FR2986538B1 (fr) | Utilisation du mir-199a-5p de ses cibles et/ou inhibiteurs pour le diagnostic, le pronostic et le traitement des pathologies fibroproliferatives |